Tratamento da forma neovascular de degeneração macular relacionada à idade com drogas antiangiogênicas

Related authors

• Eduardo Büchele Rodrigues
• Eglas Emanuel Rossi
• Astor Grumann Junior
• Carsten H. Meyer
• Allen C. Ho

Related articles

• Age-related macular degeneration: a review of current therapies and new treatments
• Is there a relationship between the first-day results of anti-VEGF therapy for macular edema due to vascular diseases and longterm outcomes?
• ETDRS panretinal photocoagulation combined with intravitreal ranibizumab versus PASCAL panretinal photocoagulation with intravitreal ranibizumab versus intravitreal ranibizumab alone for the treatment of proliferative diabetic retinopathy
• Evaluation of contrast sensitivity in non-high-risk proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal injections of ranibizumab
• Three versus five intravitreal aflibercept injections as the initial loading phase in the treatment of diabetic macular edema: one-year results
• Profile of patients treated with intravitreal antiangiogenics in a Brazilian public service with high level of complexity
• Changes in the ganglion cell complex thickness after anti-VEGF treatment for diabetic macular edema
• Switch to aflibercept in the treatment of neovascular age-related macular degeneration: 30-month results
• Prospective evaluation of the effectiveness of combined treatment of macular edema secondary to retinal vein occlusion with intravitreal bevacizumab and dexamethasone implants
• Benzoporphyrin (verteporfin) photodynamic therapy for choroidal neovascularization in age-related macular degeneration

Click here to search